STOCK TITAN

Director at Streamex Corp. (STEX) receives 100,000 restricted shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Streamex Corp. director Kevin Roy Gopaul reported an equity grant in a Form 4 filing. On January 5, 2026, he was awarded 100,000 shares of Streamex common stock as a restricted stock award, coded as an acquisition. The filing shows a transaction price of $0 per share, reflecting that this was a grant rather than a market purchase.

According to the footnote, the award was granted under Streamex’s 2023 Equity Incentive Plan and was based on a closing market price of $3.18 per share on the grant date. Following this transaction, Gopaul beneficially owns 100,000 shares of common stock in a direct capacity.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gopaul Kevin Roy

(Last) (First) (Middle)
C/O STREAMEX CORP.
2431 ALOMA AVE STE 243

(Street)
WINTER PARK FL 32792

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Streamex Corp. [ STEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/05/2026 A 100,000 A $0(1) 100,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The restricted stock award was granted under the Issuer's 2023 Equity Incentive Plan as of January 5, 2026, based on a closing price of $3.18 per share on such date.
/s/ Kevin Roy Gopaul 01/07/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Streamex Corp. director Kevin Roy Gopaul report in this Form 4?

Kevin Roy Gopaul reported receiving a restricted stock award of 100,000 shares of Streamex Corp. common stock on January 5, 2026.

What type of transaction was disclosed for Streamex Corp. (STEX)?

The transaction was an acquisition of common stock, reported with transaction code A, representing a granted restricted stock award rather than an open-market purchase.

How many Streamex Corp. shares does Kevin Roy Gopaul own after the grant?

After the reported transaction, Kevin Roy Gopaul beneficially owns 100,000 shares of Streamex Corp. common stock.

Under which plan was the Streamex Corp. restricted stock award granted?

The restricted stock award was granted under Streamex Corp.’s 2023 Equity Incentive Plan, as noted in the footnote.

What reference price was used for the Streamex Corp. restricted stock award?

The award was based on a Streamex Corp. closing price of $3.18 per share on January 5, 2026, according to the footnote.

Is the ownership reported by Kevin Roy Gopaul direct or indirect?

The Form 4 indicates direct ownership (D) of the 100,000 shares following the restricted stock grant.

BioSig Technologies Inc

NASDAQ:BSGM

BSGM Rankings

BSGM Latest News

BSGM Latest SEC Filings

BSGM Stock Data

156.96M
25.09M
28.73%
28.66%
4.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
WESTPORT